Acadian Asset Management LLC Adamis Pharmaceuticals Corp Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020
SELL
$0.52 - $1.45 $40,284 - $112,331
-77,470 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$0.33 - $0.66 $24,744 - $49,489
74,984 Added 3016.25%
77,470 $42,000
Q1 2020

May 11, 2020
SELL
$0.33 - $0.89 $8,454 - $22,800
-25,619 Reduced 91.15%
2,486 $1,000
Q4 2019

Feb 06, 2020
BUY
$0.51 - $1.26 $14,333 - $35,412
28,105 New
28,105 $20,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email